Sale!

Epstein-Barr Virus Early RNA EBER-ISH In-Situ-Hybridization Test

970 د.إ

-10%

The Epstein-Barr Virus Early RNA (EBER) In-Situ-Hybridization (ISH) Test is a sophisticated diagnostic procedure offered by DNA Labs UAE, designed to detect the presence of Epstein-Barr Virus (EBV) in tissue samples. EBV is known for its association with various diseases, including infectious mononucleosis, certain types of cancer such as Hodgkin’s lymphoma, and other lymphoproliferative disorders. The EBER-ISH test is highly sensitive and specific for EBV, making it a valuable tool in the diagnostic process.

This test utilizes the in-situ hybridization technique to identify small RNA fragments, known as EBERs, which are abundantly expressed in cells infected with EBV. By applying a labeled probe that specifically binds to EBER RNA, the presence of EBV-infected cells can be visualized under a microscope, providing direct evidence of EBV infection in the tissue sample.

The cost of the EBER-ISH test at DNA Labs UAE is 970 AED. The price reflects the advanced technology and expertise required to perform this specialized diagnostic test. For patients undergoing diagnosis for conditions potentially related to EBV infection, the EBER-ISH test offers a high level of accuracy, aiding healthcare providers in making informed decisions about patient care and treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EPSTEIN-BARR VIRUS EARLY RNA EBER-ISH IN-SITU-HYBRIDIZATION Test

Test Name: EPSTEIN-BARR VIRUS EARLY RNA EBER-ISH IN-SITU-HYBRIDIZATION Test

Components: Price: 970.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathologyreport, Site of biopsy and Clinical history.

Report Delivery: 10-12 days

Method: In-Situ-Hybridization

Test type: Cancer

Doctor: Oncologist

Test Department:

Pre Test Information: Provide a copy of the Histopathologyreport, Site of biopsy and Clinical history.

Test Details

The Epstein-Barr Virus Early RNA (EBER-ISH) In-Situ-Hybridization test is a laboratory technique used to detect the presence of Epstein-Barr virus (EBV) in tissues or cells. Epstein-Barr virus is a common virus that infects most people at some point in their lives. It is associated with various diseases, including infectious mononucleosis, certain types of cancer (such as Burkitt’s lymphoma and nasopharyngeal carcinoma), and autoimmune disorders.

The EBER-ISH test uses specific probes that bind to the early RNA molecules produced by the Epstein-Barr virus during its replication cycle. These probes are labeled with a detectable marker, such as a fluorescent dye or an enzyme, which allows visualization of the virus in the tissue or cells under a microscope. During the test, tissue samples or cells are collected and fixed onto slides. The EBER probes are then applied to the slides and allowed to hybridize (bind) to the viral RNA if it is present. After washing off any unbound probes, the slides are examined under a microscope to detect the presence of the labeled probes, indicating the presence of Epstein-Barr virus.

The EBER-ISH test is highly sensitive and specific for detecting Epstein-Barr virus, even at low levels. It is particularly useful in diagnosing Epstein-Barr virus-associated malignancies, as well as monitoring the effectiveness of treatment in these cases. Overall, the EBER-ISH test plays a crucial role in the diagnosis and management of Epstein-Barr virus-related diseases.

Test Name EPSTEIN-BARR VIRUS EARLY RNA EBER-ISH IN-SITU-HYBRIDIZATION Test
Components
Price 970.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathologyreport, Site of biopsy and Clinical history.
Report Delivery 10-12 days
Method In-Situ-Hybridization
Test type Cancer
Doctor Oncologist
Test Department:
Pre Test Information Provide a copy of the Histopathologyreport, Site of biopsy and Clinical history.
Test Details

The Epstein-Barr Virus Early RNA (EBER-ISH) In-Situ-Hybridization test is a laboratory technique used to detect the presence of Epstein-Barr virus (EBV) in tissues or cells.

Epstein-Barr virus is a common virus that infects most people at some point in their lives. It is associated with various diseases, including infectious mononucleosis, certain types of cancer (such as Burkitt’s lymphoma and nasopharyngeal carcinoma), and autoimmune disorders.

The EBER-ISH test uses specific probes that bind to the early RNA molecules produced by the Epstein-Barr virus during its replication cycle. These probes are labeled with a detectable marker, such as a fluorescent dye or an enzyme, which allows visualization of the virus in the tissue or cells under a microscope.

During the test, tissue samples or cells are collected and fixed onto slides. The EBER probes are then applied to the slides and allowed to hybridize (bind) to the viral RNA if it is present. After washing off any unbound probes, the slides are examined under a microscope to detect the presence of the labeled probes, indicating the presence of Epstein-Barr virus.

The EBER-ISH test is highly sensitive and specific for detecting Epstein-Barr virus, even at low levels. It is particularly useful in diagnosing Epstein-Barr virus-associated malignancies, as well as monitoring the effectiveness of treatment in these cases.

Overall, the EBER-ISH test plays a crucial role in the diagnosis and management of Epstein-Barr virus-related diseases.